BioCentury
ARTICLE | Company News

Actelion, Celltech Group deal

June 21, 2004 7:00 AM UTC

The companies modified a 2002 deal between ATLN and Oxford GlycoSciences plc related to Oxford's Zavesca N-butyldeoxynojirimycin glucosyltransferase (see BioCentury, July 29, 2002). As revised, ATL...